Investors should buy Lufax as the China-based lending company pivots, according to Sanford C. Bernstein. Analyst Tianjiao Yu initiated coverage of the financial technology stock at outperform. The firm's $2.50 price target for U.S.-listed shares implies 59% upside from where the shares closed Wednesday.
Competition is more crowded in consumer lending, and banks are not competitors, but rather "hand-holding partners" in the small- and medium-sized enterprise space as they rely on Lufax for customer acquisition and data, Yu noted. Yu said Lufax could see "take rates" move to 3% at the end of 2027 from 1.3% at the end of 2023 under its full-guarantee model with incremental guarantee income.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
स्रोत: nypost - 🏆 91. / 67 और पढो »